Dr Rowland Illing, AWS Chief Medical Officer, explained how generative AI can unify global datasets and track superbugs to address antimicrobial resistance (AMR), where changing microorganisms render standard treatments ineffective. The Fleming Initiative, a joint venture of Imperial College London and Imperial College Healthcare NHS Trust, is tackling AMR. Amazon Web Services (AWS) is providing technical support, including up to several million pounds worth of cloud and gen AI technology, for a global AMR intelligence platform the Initiative is building. This support aims to better connect data, researchers, clinicians and public health stakeholders to combat what is predicted to cause 39 million deaths from 2025 to 2050. Progress remains slow due to fragmented surveillance systems, siloed research, and limited access to integrated real-world data. With AWS' help, the Initiative will use gen AI to screen a library of more than 100,000 compounds, compressing years of lab work into weeks. Speaking at the One Health Summit in Lyon, France, under the G7 presidency of France, Professor the Lord Darzi of Denham, Executive Chair of the Fleming Initiative, described the AMR landscape as an interconnected ecosystem, stating the opportunity is to turn data into action at the speed and scale the threat demands. The project is bringing together fragmented AMR datasets to build a centralized, cloud-based platform, marking the first time these disparate datasets will be unified.